BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2489401)

  • 1. [Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
    Rahal K
    Arch Inst Pasteur Alger; 1989; 57():213-48. PubMed ID: 2489401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of pefloxacin.
    Husson MO; Izard D; Bouillet L; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
    Weinstein MP
    Diagn Microbiol Infect Dis; 1988 Dec; 11(4):195-200. PubMed ID: 3071448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
    Dolna I; Ruczkowska J; Chomontowicz M
    Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
    Berardi-Grassias L; Bigel ML; Macheboeuf F; Boisivon A; Chauvière P; Guiomar C
    Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group.
    Jones RN
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):551-6. PubMed ID: 2504598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC; Marchou B; Michéa-Hamzehpour M; Auckenthaler R
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():11-8. PubMed ID: 3086276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
    Soussy CJ; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.